Nursing Care of Dyspnea: The 6th Vital Sign in Individuals with ...
Nursing Care of Dyspnea: The 6th Vital Sign in Individuals with ...
Nursing Care of Dyspnea: The 6th Vital Sign in Individuals with ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Nurs<strong>in</strong>g</strong> Best Practice Guidel<strong>in</strong>eVacc<strong>in</strong>ation121MedicationsInfluenza Vacc<strong>in</strong>ation• 0.5ml IMosteltamivir (Tamiflu)• PO 75 mg x 5 days beg<strong>in</strong> treatment <strong>with</strong><strong>in</strong>2 days <strong>of</strong> onset <strong>of</strong> symptomsPneumo 23(Pneumococcal Polysaccharide Vacc<strong>in</strong>e)• IM/SC immuniz<strong>in</strong>g dose is a s<strong>in</strong>gle <strong>in</strong>jection<strong>of</strong> 0.5 ml• Revacc<strong>in</strong>ation: One <strong>in</strong>jection <strong>of</strong> 0.5 mlPneumovax 23(Pneumococcal Vacc<strong>in</strong>e)• Adm<strong>in</strong>ister a s<strong>in</strong>gle 0.5 ml dose <strong>of</strong> thevacc<strong>in</strong>e SC or IM (preferably <strong>in</strong> the deltoidmuscle or lateral thigh)Actions• Inhibits <strong>in</strong>fluenza virusneuram<strong>in</strong>idase <strong>with</strong>possible alteration <strong>of</strong>virus particle aggregationand releaseSide Effects• pa<strong>in</strong> and/orerythema at<strong>in</strong>jection site• anaphylaxis• headache• fatigue• nausea• vomit<strong>in</strong>g• diarrhea• cough• abdom<strong>in</strong>al pa<strong>in</strong>• pa<strong>in</strong> and/orerythema at the<strong>in</strong>jection site• headache• general malaise• uticaria• anaphylaxisreaction• pa<strong>in</strong> and/orerythema at the<strong>in</strong>jection site• headache• low grade fever• anaphylaxisreactionPharmacok<strong>in</strong>etics<strong>Nurs<strong>in</strong>g</strong> ConsiderationsAbsorption: rapidly absorbedDistribution: prote<strong>in</strong> b<strong>in</strong>d<strong>in</strong>g is lowMetabolism: converted tooseltamivir carboxylateExcretion: elim<strong>in</strong>ated by conversionHalf-Life: 1-3 hoursGive <strong>in</strong>jection whennot contra<strong>in</strong>dicated(e.g., egg allergy,thimersol sensitivity)Revacc<strong>in</strong>ationrecommended for highrisk patients every 5-10years.RNAO Guidel<strong>in</strong>e Development Panel, 2005121
Change language